Shares of Ironwood Pharma (NASDAQ: IRWD) are down 13 percent early after reporting unaudited Q1 EPS of ($0.87), $0.23 worse ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE